Pharmarise Holdings Corp.

40
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3802320006
JPY
513.00
2 (0.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Pharmarise Holdings Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
May'25
May'24
May'23
May'22
May'21
May'20
No of Months
12
12
12
12
12
12
Profit Before Tax
8.00
143.00
1,049.00
1,322.00
1,202.00
819.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
39.00
1,785.00
595.00
-1,203.00
-77.00
-431.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,311.00
2,714.00
2,520.00
713.00
1,945.00
1,572.00
Cash Flow from Investing Activities
-4,462.00
-3,120.00
-703.00
-292.00
-1,076.00
-734.00
Cash Flow from Financing Activities
939.00
2,771.00
-1,072.00
-1,034.00
-728.00
-766.00
Net Cash Inflow / Outflow
-2,212.00
2,365.00
745.00
-613.00
141.00
72.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Pharmarise Holdings Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
8
143.763
-135.00
-94.44%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
39
-15.321
54.00
354.55%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1311
-176.342
1,487.00
843.44%
Cash Flow from Investing Activities
-4462
382.147
-4,844.00
-1267.61%
Cash Flow from Financing Activities
939
-52.182
991.00
1899.47%
Net Cash Inflow / Outflow
-2212
153.623
-2,365.00
-1539.89%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - May'25
stock-summary

YoY Growth in year ended May 2025 is -51.69% vs 7.70% in May 2024

May'25
May'24
Change(%)
Cash Flow from Operating Activities
1,311.00
2,714.00
-51.69%